Holen Sie sich die Stockscreener-App
13.01
2.25%
-0.30
Handel nachbörslich:
13.07
0.06
+0.46%
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.18%
66.77
|
59.52 | 51.44 | 49.25 | 45.85 |
| Operating Income/Loss |
12.18%
-66.77
|
-59.52 | -51.44 | -49.25 | -45.85 |
| Income/Loss From Continuing Operations Before Tax |
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
| Income/Loss From Continuing Operations After Tax |
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
|
Net Income/Loss
|
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4,046%
86.68
|
2.0908 | 85.95 | 74.96 | 71.97 |
| Diluted Average Shares |
4,046%
86.68
|
2.0908 | 85.95 | 74.96 | 71.97 |
| Basic Earnings Per Share |
12.50%
-0.72
|
-0.64 | -0.54 | -0.61 | -0.59 |
| Diluted Earnings Per Share |
12.50%
-0.72
|
-0.64 | -0.54 | -0.61 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):